Skip Navigation
Centers for Disease Control & Prevention
  Sexually Transmitted Diseases

  STD Research

Use your browser's BACK button to return to your page of origin.

Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.

Journal of Infectious Diseases 2000;181(4):1421-1427.

Somani J, Bhuller VB, Workowski KA, Farshy CE, Black CM.

Abstract
In vitro susceptibility testing and genotyping were done on urogenital isolates of Chlamydia trachomatis from 3 patients, 2 of whom showed evidence of clinical treatment failure with azithromycin and one of whom was the wife of a patient. All 3 isolates demonstrated multidrug resistance to doxycycline, azithromycin, and ofloxacin at concentrations >4.0 microg/mL. Recurrent disease due to relapsing infection with the same resistant isolate was documented on the basis of identical genotypes of both organisms. This first report of clinically significant multidrug-resistant C. trachomatis causing relapsing or persistent infection may portend an emerging problem to clinicians and public health officials.



Page last modified: August 8, 2005
Page last reviewed: August 8, 2005 Historical Document

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention